NO20000573D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number: NO20000573D0
Authority: NO; Norway
Prior art keywords: sup; formula; chemical connections; mcp; disease
Prior art date: 1997-08-07

Application number

NO20000573A

Other languages

English (en)

Norwegian (no)

Other versions

NO20000573L (no

Inventor

Andrew John Barker

Jason Grant Kettle

Alan Wellington Faull

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-07

Filing date

2000-02-04

Publication date

2000-02-04

2000-02-04 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

2000-02-04 Publication of NO20000573L publication Critical patent/NO20000573L/no

2000-02-04 Publication of NO20000573D0 publication Critical patent/NO20000573D0/no

Links

101710155857 C-C motif chemokine 2 Proteins 0.000 abstract 2
102000000018 Chemokine CCL2 Human genes 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
External Artificial Organs (AREA)
Mechanical Coupling Of Light Guides (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20000573A 1997-08-07 2000-02-04 Kjemiske forbindelser NO20000573D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9716657.3A GB9716657D0 (en)	1997-08-07	1997-08-07	Chemical compounds
PCT/GB1998/002341 WO1999007351A2 (en)	1997-08-07	1998-08-04	Indole derivatives and their use as mcp-1 antagonists

Publications (2)

Publication Number	Publication Date
NO20000573L NO20000573L (no)	2000-02-04
NO20000573D0 true NO20000573D0 (no)	2000-02-04

Family

ID=10817097

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000573A NO20000573D0 (no)	1997-08-07	2000-02-04	Kjemiske forbindelser

Country Status (27)

Country	Link
US (2)	US6441004B1 (de)
EP (1)	EP1003504B1 (de)
JP (1)	JP3863722B2 (de)
KR (1)	KR20010022318A (de)
CN (1)	CN1265591A (de)
AT (1)	ATE244007T1 (de)
AU (1)	AU745907C (de)
BR (1)	BR9811818A (de)
CA (1)	CA2297290A1 (de)
CZ (1)	CZ294600B6 (de)
DE (1)	DE69816091T2 (de)
DK (1)	DK1003504T3 (de)
ES (1)	ES2201517T3 (de)
GB (1)	GB9716657D0 (de)
HR (1)	HRP20000061A2 (de)
HU (1)	HUP0004301A3 (de)
ID (1)	ID23666A (de)
IL (1)	IL133989A0 (de)
NO (1)	NO20000573D0 (de)
NZ (1)	NZ502056A (de)
PL (1)	PL338948A1 (de)
PT (1)	PT1003504E (de)
RU (1)	RU2217142C2 (de)
SK (1)	SK284408B6 (de)
TR (1)	TR200000289T2 (de)
WO (1)	WO1999007351A2 (de)
ZA (1)	ZA987090B (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
FR2768146B1 (fr)	1997-09-05	2000-05-05	Oreal	Nouveaux composes de la famille des indole-carboxyliques et leur utilisation
GB9902453D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
FR2796274B1 (fr)	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2796279B1 (fr)	1999-07-16	2001-09-21	Oreal	Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
GB0000626D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en) *	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
AU2002211901A1 (en)	2000-10-10	2002-04-22	Smithkline Beecham Corporation	Substituted indoles, pharmaceutical compositions containing such indoles and their use as PPAR-gamma binding agents
US6706712B2 (en)	2000-12-20	2004-03-16	Bristol-Myers Squibb Pharma Company	Cyclic derivatives as modulators of chemokine receptor activity
WO2002050019A2 (en)	2000-12-20	2002-06-27	Bristol-Myers Squibb Pharma Co.	Diamines as modulators of chemokine receptor activity
EP1368354A1 (de)	2001-03-07	2003-12-10	Pfizer Products Inc.	Modulatoren der aktivität von chemokin-rezeptoren
ES2180436B1 (es) *	2001-06-04	2003-11-01	Menarini Lab	Nuevos indoles como inhibidores de la ciclooxigenasa- ii
EP1314733A1 (de) *	2001-11-22	2003-05-28	Aventis Pharma Deutschland GmbH	Indol-2-carbonsäureamide als Faktor-Xa-Hemmer
EP1531822B1 (de)	2002-06-12	2009-08-05	ChemoCentryx Inc	1-aryl-4-substituierte piperazin-derivate zur verwendung als ccr1-antagonisten zur behandlung von entzündungen und immunerkrankungen
US7842693B2 (en)	2002-06-12	2010-11-30	Chemocentryx, Inc.	Substituted piperazines
US7589199B2 (en)	2002-06-12	2009-09-15	Chemocentryx, Inc.	Substituted piperazines
US7338975B2 (en)	2003-02-12	2008-03-04	Bristol-Myers Squibb Co.	Lactams as modulators of chemokine receptor activity
TW200508224A (en)	2003-02-12	2005-03-01	Bristol Myers Squibb Co	Cyclic derivatives as modulators of chemokine receptor activity
RU2366655C2 (ru)	2003-03-14	2009-09-10	Оно Фармасьютикал Ко., Лтд.	Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
CA2522543A1 (en) *	2003-04-14	2004-10-28	Surface Logix, Inc.	Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
WO2004092169A1 (ja)	2003-04-18	2004-10-28	Ono Pharmaceutical Co., Ltd.	スピロピペリジン化合物およびその医薬用途
US7291615B2 (en)	2003-05-01	2007-11-06	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
US7230133B2 (en)	2003-05-01	2007-06-12	Bristol-Myers Squibb Company	Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7732162B2 (en)	2003-05-05	2010-06-08	Probiodrug Ag	Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2004108671A1 (en) *	2003-06-06	2004-12-16	Suven Life Sciences Limited	Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
SE0302035D0 (sv) *	2003-07-09	2003-07-09	Biolipox Ab	New compound
US7332521B2 (en) *	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7479496B2 (en)	2004-02-19	2009-01-20	Bristol-Myers Squibb Company	Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7381738B2 (en)	2004-02-19	2008-06-03	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7288563B2 (en)	2004-02-19	2007-10-30	Bristol-Myers Squibb Company	Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7230022B2 (en)	2004-02-19	2007-06-12	Bristol-Myers Squibb Company	Substituted fused bicyclic amines as modulators of chemokine receptor activity
US7435831B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
US7435830B2 (en)	2004-03-03	2008-10-14	Chemocentryx, Inc.	Bicyclic and bridged nitrogen heterocycles
WO2005101002A1 (en) *	2004-04-13	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 2 (ccr2)
US8481035B2 (en)	2004-04-27	2013-07-09	Northwestern University	Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
AU2005254783A1 (en) *	2004-06-18	2005-12-29	Biolipox Ab	Indoles useful in the treatment of inflammation
ES2315877T3 (es)	2004-06-18	2009-04-01	Biolipox Ab	Indoles utiles en el tratamiento de inflamaciones.
US20080146616A1 (en) *	2004-06-18	2008-06-19	Kristofer Olofsson	Indoles Useful in the Treatment of Inflammation
EP1781609A4 (de) *	2004-07-01	2009-07-29	Univ California	Inhibierung einer pdz-domänen-wechselwirkung durch kleine moleküle
US8143404B2 (en)	2004-09-13	2012-03-27	Ono Pharmaceutical Co., Ltd	Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
GB0428173D0 (en) *	2004-12-23	2005-01-26	Astrazeneca Ab	Compounds
EP1676834A1 (de)	2004-12-30	2006-07-05	Sanofi-Aventis Deutschland GmbH	Kondensierte Bicyclische Carboxamid-Derivate zur Verwendung als CXCR2 Inhibitoren zur Behandlung von Entzündungen
CN101142185A (zh) *	2005-01-19	2008-03-12	比奥里波克斯公司	用于炎症治疗的吲哚
JP2008527030A (ja) *	2005-01-19	2008-07-24	バイオリポックスエービー	炎症の治療に有用なインドール類
EP1841766A1 (de) *	2005-01-19	2007-10-10	Biolipox AB	Entzündungshemmende pyrrolopyridin-derivate
US20090042949A1 (en) *	2005-01-19	2009-02-12	Benjamin Pelcman	Indoles Useful in the Treatment of Inflammation
CA2594665A1 (en) *	2005-01-19	2006-07-27	Biolipox Ab	Thienopyrroles useful in the treatment of inflammation
EP1844013A1 (de) *	2005-01-19	2007-10-17	Biolipox AB	Zur behandlung von entzündungen geeignete indole
EP1889622A4 (de)	2005-05-31	2009-12-23	Ono Pharmaceutical Co	Spiropiperidinverbindung und deren medizinische verwendung
EP2657235A1 (de)	2005-10-28	2013-10-30	Ono Pharmaceutical Co., Ltd.	Verbindung mit basischer Gruppe und Verwendung davon
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
WO2007058322A1 (ja)	2005-11-18	2007-05-24	Ono Pharmaceutical Co., Ltd.	塩基性基を含有する化合物およびその用途
UA95788C2 (en)	2005-12-15	2011-09-12	Ф. Хоффманн-Ля Рош Аг	Fused pyrrole derivatives
CA2644368A1 (en)	2006-03-10	2007-09-20	Ono Pharmaceutical Co., Ltd.	Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
US7732287B2 (en) *	2006-05-02	2010-06-08	Honeywell International Inc.	Method of forming a body-tie
WO2007132846A1 (ja)	2006-05-16	2007-11-22	Ono Pharmaceutical Co., Ltd.	保護されていてもよい酸性基を含有する化合物およびその用途
JP5352454B2 (ja)	2006-06-28	2013-11-27	サノフイ	Ｃｘｃｒ２アンンタゴニスト
CA2656150A1 (en)	2006-06-28	2008-01-03	Sanofi-Aventis	New cxcr2 inhibitors
EP2040690B1 (de)	2006-06-28	2014-08-06	Sanofi	Cxcr2-inhibitoren
JP5352455B2 (ja)	2006-06-30	2013-11-27	サノフイ	Ｃｘｃｒ２阻害剤
JP5245827B2 (ja)	2006-07-31	2013-07-24	小野薬品工業株式会社	スピロ結合した環状基を含有する化合物およびその用途
JP5275236B2 (ja)	2006-09-29	2013-08-28	スミスクラインビーチャムコーポレーション	置換されたインドール化合物
CA2665808A1 (en) *	2006-10-05	2008-05-22	Centocor Ortho Biotech Inc.	Ccr2 antagonists for treatment of fibrosis
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
ATE554085T1 (de)	2006-11-30	2012-05-15	Probiodrug Ag	Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja)	2007-03-01	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤の新規使用
MY162157A (en) *	2007-04-16	2017-05-31	Abbott Lab	Substituted indole mcl-1 inhibitors
CA2951295C (en)	2007-04-16	2020-04-28	Abbvie Inc.	7-nonsubstituted indole mcl-1 inhibitors
EP2142514B1 (de)	2007-04-18	2014-12-24	Probiodrug AG	Thioharnstoffderivate als glutaminylcyclaseinhibitoren
JP5580735B2 (ja) *	2007-06-12	2014-08-27	ジェネンテック，インコーポレイテッド	Ｎ−置換アザインドール類及び使用方法
JP2011509156A (ja)	2008-01-08	2011-03-24	イェールユニバーシティ	血管移植片の開存性を促進するための組成物および方法
US7964897B2 (en)	2008-07-22	2011-06-21	Honeywell International Inc.	Direct contact to area efficient body tie process flow
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
JP5934645B2 (ja)	2009-09-11	2016-06-15	プロビオドルグエージー	グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
JP6026284B2 (ja)	2010-03-03	2016-11-16	プロビオドルグエージー	グルタミニルシクラーゼの阻害剤
NZ602312A (en)	2010-03-10	2014-02-28	Probiodrug Ag	Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
EP2686313B1 (de)	2011-03-16	2016-02-03	Probiodrug AG	Benzimidazolderivate als glutaminylcyclase-hemmer
EP2731439A4 (de) *	2011-07-12	2014-12-03	Merck Sharp & Dohme	Trka-kinase-hemmer, zusammensetzungen daraus und verfahren dafür
US8883857B2 (en)	2012-12-07	2014-11-11	Baylor College Of Medicine	Small molecule xanthine oxidase inhibitors and methods of use
TWI735416B (zh)	2014-10-06	2021-08-11	美商維泰克斯製藥公司	囊腫纖維化症跨膜傳導調節蛋白之調節劑
WO2017100782A1 (en)	2015-12-11	2017-06-15	Research Institute At Nationwide Children's Hospital	Systems and methods for optimized patent specific tissue engineering vascular grafts
ES2946970T3 (es)	2016-03-31	2023-07-28	Vertex Pharma	Regulador de conductancia transmembrana de moduladores de fibrosis quística
SI3519401T1 (sl)	2016-09-30	2022-01-31	Vertex Pharmaceuticals Incorporated	Modulator regulatorja transmembranske prevodnosti pri cistični fibrozi, farmacevtski sestavki, postopki zdravljenja in proces za izdelavo modulatorja
WO2018106945A1 (en)	2016-12-07	2018-06-14	Progenity Inc.	Gastrointestinal tract detection methods, devices and systems
CN110267948B (zh)	2016-12-09	2023-12-08	弗特克斯药品有限公司	囊性纤维化跨膜传导调控剂的调节剂、药物组合物、治疗方法和制备所述调节剂的方法
EP3554541B1 (de)	2016-12-14	2023-06-07	Biora Therapeutics, Inc.	Behandlung einer erkrankung des gastrointestinaltraktes mit einem chemokin/chemokin-rezeptor-inhibitor
WO2018191146A1 (en) *	2017-04-10	2018-10-18	Navitor Pharmaceuticals, Inc.	Heteroaryl rheb inhibitors and uses thereof
AU2018279646B2 (en)	2017-06-08	2023-04-06	Vertex Pharmaceuticals Incorporated	Methods of treatment for cystic fibrosis
MA49631A (fr)	2017-07-17	2020-05-27	Vertex Pharma	Méthodes de traitement de la fibrose kystique
TWI799435B (zh)	2017-08-02	2023-04-21	美商維泰克斯製藥公司	製備化合物之製程
ES2812698T3 (es)	2017-09-29	2021-03-18	Probiodrug Ag	Inhibidores de glutaminil ciclasa
US10654829B2 (en)	2017-10-19	2020-05-19	Vertex Pharmaceuticals Incorporated	Crystalline forms and compositions of CFTR modulators
KR102716244B1 (ko)	2017-12-08	2024-10-14	버텍스 파마슈티칼스 인코포레이티드	낭포성 섬유증 막횡단 전도 조절자의 조정제의 제조 방법
TWI810243B (zh)	2018-02-05	2023-08-01	美商維泰克斯製藥公司	用於治療囊腫纖化症之醫藥組合物
EP3774825A1 (de)	2018-04-13	2021-02-17	Vertex Pharmaceuticals Incorporated	Modulatoren des transmembranleitfähigkeitsreglers von zystischer fibrose, pharmazeutische zusammensetzungen, behandlungsverfahren und verfahren zur herstellung des modulators
EP3883635A1 (de)	2018-11-19	2021-09-29	Progenity, Inc.	Verfahren und vorrichtungen zur behandlung einer krankheit mit biotherapeutika
CN115666704B (zh)	2019-12-13	2025-09-26	比特比德科有限责任公司	用于将治疗剂递送至胃肠道的可摄取装置
CN121758351A (zh) *	2026-03-03	2026-03-31	云南省农业科学院茶叶研究所	一种2-羧酸酯吲哚衍生物的制备方法

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3557142A (en)	1968-02-20	1971-01-19	Sterling Drug Inc	4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
US3776923A (en)	1970-01-06	1973-12-04	American Cyanamid Co	2-nitro-4-oxo-4,5,6,7-tetrahydroindole
US3997557A (en)	1974-04-23	1976-12-14	American Hoechst Corporation	Substituted N-aminoalkylpyrroles
DE3115993A1 (de) *	1981-04-13	1982-11-11	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Neue indol-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
US4384994A (en)	1981-10-08	1983-05-24	Merck & Co., Inc.	Renin inhibitory peptides
US4496742A (en)	1981-10-13	1985-01-29	The Upjohn Company	Analogs of 5,6-dihydro PGI2
FR2537974A1 (fr)	1982-12-16	1984-06-22	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4529724A (en)	1983-10-11	1985-07-16	Mcneilab, Inc.	6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3342688A1 (de)	1983-11-25	1985-06-05	Siemens AG, 1000 Berlin und 8000 München	Roentgenroehre
FR2565981B1 (fr)	1984-06-15	1986-09-19	Adir	Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
JPS61502818A (ja)	1984-07-30	1986-12-04	シェリング・コ−ポレ−ション	シス、エンド−オクタヒドロシクロペンタ〔ｂ〕ピロ−ル−２−カルボキシレ−トの新規製造方法
PH23498A (en) *	1984-08-06	1989-08-16	Sterling Drug Inc	3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
JPS61100565A (ja) *	1984-10-22	1986-05-19	Green Cross Corp:The	インド−ル酢酸誘導体
US4675332A (en)	1984-12-10	1987-06-23	Warner-Lambert Company	Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
DE3568431D1 (en)	1984-12-12	1989-04-06	Merck & Co Inc	Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4721725A (en)	1986-01-27	1988-01-26	E. R. Squibb & Sons, Inc.	Aryl-cycloalkyl[b]pyrrole derivatives
NZ222878A (en)	1986-12-17	1991-02-26	Merck Frosst Canada Inc	3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
US4751231A (en)	1987-09-16	1988-06-14	Merck & Co., Inc.	Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
DE3907388A1 (de)	1989-03-08	1990-09-13	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von indolcarbonsaeurederivaten
NZ234883A (en)	1989-08-22	1995-01-27	Merck Frosst Canada Inc	Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
US5272145A (en)	1989-08-22	1993-12-21	Merck Frosst Canada, Inc.	(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
DE3943225A1 (de)	1989-12-23	1991-06-27	Schering Ag	Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5081145A (en)	1990-02-01	1992-01-14	Merck Frosst Canada, Inc.	Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5068234A (en) *	1990-02-26	1991-11-26	Sterling Drug Inc.	3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
US5260322A (en)	1990-10-08	1993-11-09	Merck & Co., Inc.	Angiotension II antagonists in the treatment of hyperuricemia
CA2079374C (en)	1991-09-30	2003-08-05	Merck Frosst Canada Incorporated	(bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5290798A (en)	1991-09-30	1994-03-01	Merck Frosst Canada, Inc.	(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5389650A (en)	1991-09-30	1995-02-14	Merck Frosst Canada, Inc.	(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en)	1991-09-30	1993-12-28	Merck Frosst Canada Inc.	Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5190968A (en)	1991-09-30	1993-03-02	Merck Frosst Canada, Inc.	(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en)	1991-09-30	1994-05-03	Merck Frosst Canada, Inc.	(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
RU2047603C1 (ru) *	1991-12-09	1995-11-10	Матвей Абрамович Рехтер	1-алкил-2-ацилиндолы и способы их получения
US5318985A (en)	1991-12-20	1994-06-07	Merrell Dow Pharmaceuticals Inc.	Potentiation of NMDA antagonists
WO1993016069A1 (en)	1992-02-13	1993-08-19	Merck Frosst Canada Inc.	(azaaromaticalkoxy)indoles as inhibitors of leukotriene biosynthesis
ES2150941T3 (es)	1992-04-03	2000-12-16	Upjohn Co	Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
US5334719A (en)	1992-06-17	1994-08-02	Merck Frosst Canada, Inc.	Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
US5288743A (en)	1992-11-20	1994-02-22	Abbott Laboratories	Indole carboxylate derivatives which inhibit leukotriene biosynthesis
ZA939516B (en)	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
US5852046A (en)	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
EP0639573A1 (de)	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
US5401287A (en)	1993-08-19	1995-03-28	Ppg Industries, Inc.	Reduction of nickel sulfide stones in a glass melting operation
US5399699A (en)	1994-01-24	1995-03-21	Abbott Laboratories	Indole iminooxy derivatives which inhibit leukotriene biosynthesis
HUT76923A (hu)	1994-07-27	1998-01-28	Sankyo Company Limited	Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
US5482960A (en)	1994-11-14	1996-01-09	Warner-Lambert Company	Nonpeptide endothelin antagonists
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
WO1996018393A1 (en) *	1994-12-13	1996-06-20	Smithkline Beecham Corporation	Novel compounds
ATE243203T1 (de)	1995-04-04	2003-07-15	Texas Biotechnology Corp	Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
IT1282797B1 (it)	1995-04-21	1998-03-31	Colla Paolo	Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
US5639780A (en)	1995-05-22	1997-06-17	Merck Frosst Canada, Inc.	N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US5604253A (en)	1995-05-22	1997-02-18	Merck Frosst Canada, Inc.	N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
AU6966696A (en)	1995-10-05	1997-04-28	Warner-Lambert Company	Method for treating and preventing inflammation and atherosclerosis
ES2199348T4 (es)	1996-02-26	2010-10-19	ADVANCED RESEARCH & TECHNOLOGY INSTITUTE	Uso de inhibidores de carbonico anhidrasa para el tratamiento del edema macular.
JP3540495B2 (ja) *	1996-03-18	2004-07-07	三菱重工業株式会社	水素分離膜
EP1021181A4 (de)	1996-03-28	2002-06-26	Smithkline Beecham Corp	Indolcarbonsäuren als chemokin-inhibitoren
EP0822185A1 (de)	1996-07-31	1998-02-04	Pfizer Inc.	Beta-3-adrenergische Agonisten als antidiabetische Mittel und als Mittel gegen Fettsucht
WO1998006703A1 (en)	1996-08-14	1998-02-19	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716657D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9716656D0 (en) *	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
DK1042287T3 (da)	1997-12-24	2005-08-15	Aventis Pharma Gmbh	Indolderivater som inhibitorer af faktor Xa
GB9803228D0 (en) *	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9803226D0 (en) *	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000626D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds

1997
- 1997-08-07 GB GBGB9716657.3A patent/GB9716657D0/en active Pending
1998
- 1998-08-04 DE DE69816091T patent/DE69816091T2/de not_active Expired - Fee Related
- 1998-08-04 PT PT98937659T patent/PT1003504E/pt unknown
- 1998-08-04 IL IL13398998A patent/IL133989A0/xx unknown
- 1998-08-04 SK SK167-2000A patent/SK284408B6/sk unknown
- 1998-08-04 AU AU86381/98A patent/AU745907C/en not_active Ceased
- 1998-08-04 NZ NZ502056A patent/NZ502056A/en unknown
- 1998-08-04 TR TR2000/00289T patent/TR200000289T2/xx unknown
- 1998-08-04 CN CN98807795A patent/CN1265591A/zh active Pending
- 1998-08-04 JP JP2000506944A patent/JP3863722B2/ja not_active Expired - Fee Related
- 1998-08-04 BR BR9811818-8A patent/BR9811818A/pt not_active IP Right Cessation
- 1998-08-04 DK DK98937659T patent/DK1003504T3/da active
- 1998-08-04 AT AT98937659T patent/ATE244007T1/de not_active IP Right Cessation
- 1998-08-04 RU RU2000105901/15A patent/RU2217142C2/ru not_active IP Right Cessation
- 1998-08-04 US US09/485,061 patent/US6441004B1/en not_active Expired - Fee Related
- 1998-08-04 CA CA002297290A patent/CA2297290A1/en not_active Abandoned
- 1998-08-04 ES ES98937659T patent/ES2201517T3/es not_active Expired - Lifetime
- 1998-08-04 HU HU0004301A patent/HUP0004301A3/hu unknown
- 1998-08-04 CZ CZ2000431A patent/CZ294600B6/cs not_active IP Right Cessation
- 1998-08-04 WO PCT/GB1998/002341 patent/WO1999007351A2/en not_active Ceased
- 1998-08-04 EP EP98937659A patent/EP1003504B1/de not_active Expired - Lifetime
- 1998-08-04 ID IDW20000172A patent/ID23666A/id unknown
- 1998-08-04 HR HR20000061A patent/HRP20000061A2/hr not_active Application Discontinuation
- 1998-08-04 KR KR1020007000897A patent/KR20010022318A/ko not_active Ceased
- 1998-08-04 PL PL98338948A patent/PL338948A1/xx unknown
- 1998-08-06 ZA ZA987090A patent/ZA987090B/xx unknown
2000
- 2000-02-04 NO NO20000573A patent/NO20000573D0/no not_active Application Discontinuation
2002
- 2002-07-15 US US10/194,969 patent/US6953809B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE244007T1 (de)	2003-07-15
RU2217142C2 (ru)	2003-11-27
DE69816091T2 (de)	2004-05-19
IL133989A0 (en)	2001-04-30
DK1003504T3 (da)	2003-10-13
AU745907B2 (en)	2002-04-11
EP1003504A2 (de)	2000-05-31
JP3863722B2 (ja)	2006-12-27
HRP20000061A2 (en)	2000-12-31
NO20000573L (no)	2000-02-04
KR20010022318A (ko)	2001-03-15
CA2297290A1 (en)	1999-02-18
NZ502056A (en)	2002-02-01
EP1003504B1 (de)	2003-07-02
US6441004B1 (en)	2002-08-27
CZ2000431A3 (cs)	2000-05-17
DE69816091D1 (de)	2003-08-07
BR9811818A (pt)	2000-08-15
CZ294600B6 (cs)	2005-02-16
HUP0004301A3 (en)	2002-10-28
AU745907C (en)	2005-02-17
PL338948A1 (en)	2000-12-04
GB9716657D0 (en)	1997-10-15
WO1999007351A3 (en)	1999-05-14
ID23666A (id)	2000-05-11
SK284408B6 (sk)	2005-03-04
HUP0004301A2 (hu)	2001-12-28
WO1999007351A2 (en)	1999-02-18
ZA987090B (en)	1999-02-08
ES2201517T3 (es)	2004-03-16
HK1027979A1 (en)	2001-02-02
US6953809B2 (en)	2005-10-11
JP2001513494A (ja)	2001-09-04
SK1672000A3 (en)	2000-12-11
AU8638198A (en)	1999-03-01
CN1265591A (zh)	2000-09-06
PT1003504E (pt)	2003-11-28
US20030119830A1 (en)	2003-06-26
TR200000289T2 (tr)	2000-08-21

Legal Events

Date	Code	Title	Description
2006-03-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20000573L (no)	2000-02-04	Kjemiske forbindelser
GB9716656D0 (en)	1997-10-15	Chemical compounds
NO20023934D0 (no)	2002-08-19	Nye forbindelser
SE9902987D0 (sv)	1999-08-24	Novel compounds
DE60001811D1 (de)	2003-04-30	Antiimflammatorische indolderivate
NO20026064D0 (no)	2002-12-17	Nye forbindelser
CY1107391T1 (el)	2010-07-28	Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
ID27178A (id)	2001-03-08	Senyawa aminosikloheksil eter dan penggunaannya
CA2260777A1 (en)	1998-02-12	Pentafluorobenzenesulfonamides and analogs
CY1105198T1 (el)	2010-03-03	Παραγωγα πιπepιδινης χρησιμα σαν ανταγωνιστες ccr5 για τη θepαπεια ιου ανθρωπινης ανοσοανεπαρκειας (hiv)
ATE369348T1 (de)	2007-08-15	Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
TR199801614T2 (xx)	1998-11-23	Peptit t�revleri
RU94038063A (ru)	1996-05-27	3-фенилуреидо-азепин-2-оны и -бензазепин-2-оны, способы их получения, промежуточные соединения, фармацевтические композиции и способы лечения